ENTITY
New Horizon Health

New Horizon Health (6606 HK)

59
Analysis
Health CareChina
New Horizon Health Limited operates cancer screening technology development business. The Company develops and sells colorectal cancer screening test products, gastric cancer screening test products, and other products. New Horizon Health markets its products throughout China.
more
17 Jan 2021 00:31

ECM Weekly (17 January 2021) - RLX Tech, Kuaishou, PTT Retail, MicroPort CardioFlow, New Horizon

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
12 Jan 2021 12:59

New Horizon Health IPO: Aiming to Become Pioneer in Cancer Screening

New Horizon Health, the pioneer in China’s colorectal cancer screening market has filed for an IPO on the Hong Kong Stock Exchange and the company...

Share
12 Jan 2021 09:24

New Horizon Health (诺辉健康) Pre-IPO: Comparison with Exact Sciences

We compare the company's product with the benchmark product, Exact Sciences' Cologuard. We think ColoClear is ahead of the Cologuard with...

Logo
447 Views
Share
10 Jan 2021 21:14

New Horizon Health IPO Initiation: Screening for Cancer

New Horizon will have a listing hearing for a $300 million HK IPO this week. We believe that New Horizon has the right ingredients to capitalise on...

Logo
473 Views
Share
bullishYidu Tech Inc
10 Jan 2021 13:45

ECM Weekly (10 January 2021) - RLX Technology, Roiserv, Yidu Tech, and Placements

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
x